EUVIMEDEUVIMED entdecken
Systematische Übersicht

Advancements in Molecular Biomarkers as Prognostic Predictors for Patients with Glioblastoma: A Systematic Review

Renindra Ananda Aman

Eurasian Journal of Medicine and Oncology · 2024 · 402-409

DOI: 10.14744/ejmo.2024.79543 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Eurasian Journal of Medicine and Oncology, 2024. Verfasst von Renindra Ananda Aman. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Glioblastoma (GBM) is a highly aggressive tumor with a median survival of 14-15 months with specific genetic expression.With advances in technology, molecular biomarkers are currently used as predictors to determine the prognosis of patients with GBM.

Methods

We collected literature through PubMed, SCOPUS, and Google scholar, from to 2014-2024. The study designs that met the inclusion criteria were cohort, cross-sectional, systematic reviews, and meta-analyses. The studies will be graded according to the risk of bias they represent using Quality of Prognosis Studies (QUIPS) Tool Ratings.

Results

Twelve articles with six different biomarkers (MGMT, IDH, PTEN, EGFR, EGFRvIII, and TP53) met the inclusion criteria and were considered eligible for this systematic review. Prognosis was measured using OS, and the data were compared using univariate analysis of each biomolecule for OS. Methylation of MGMT and IDH mutations was a good prognostic predictor, and amplification of EGFR,EGFRvIII,PTEN, and TP53 mutations was not statistically significant for OS.

Conclusion

Several biomarkers can be used as predictors alone or in combination with one another. Advances in technology and biomolecular science are expected to help predict the prognosis and provide new insights into the management of GBM.

Zitieren

APA

Aman, R. A. (2024). Advancements in Molecular Biomarkers as Prognostic Predictors for Patients with Glioblastoma: A Systematic Review. Eurasian Journal of Medicine and Oncology, 402-409. https://doi.org/10.14744/ejmo.2024.79543

Vancouver

Aman RA. Advancements in Molecular Biomarkers as Prognostic Predictors for Patients with Glioblastoma: A Systematic Review. Eurasian Journal of Medicine and Oncology. 2024:402-409. doi:10.14744/ejmo.2024.79543

BibTeX
@article{Aman2024,
  author = {Aman, Renindra Ananda},
  title = {Advancements in Molecular Biomarkers as Prognostic Predictors for Patients with Glioblastoma: A Systematic Review},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2024},
  pages = {402--409},
  doi = {10.14744/ejmo.2024.79543}
}
Kostenlos starten →